Device Trial Radar · NCT04591925
SteadiSet™ Pilot Study (SteP Study)
Last checked: Nov 20, 2026Latest source record: Feb 11, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
13
Actual
Start
Feb 5, 2021
Primary completion
Nov 2, 2021
Study completion Nov 2, 2021
Sponsor
- Lead sponsor
- Capillary Biomedical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 19, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and effectiveness of how well blood glucose is managed when a participate wears the investigational SteadiSet™ Infusion Set (SteadiSet device) for up to 14 days post-insertion when compared to a Teflon Control infusion set.
Conditions
- Diabetes Mellitus, Type I
- IDDM
- Diabetes Mellitus, Insulin-Dependent, 1
- Type 1 Diabetes
- Type 1 Diabetes Mellitus
Interventions
Control Device insulin infusion devcieDevice
Control Device - Commercially available insulin infusion device using a soft Teflon indwelling cannula
Investigative insulin infusion devcieDevice
Investigative insulin infusion device with coil-reinforced soft polymer indwelling cannula
Primary outcomes
What the sponsor says the trial is designed to measure.
- Days of successful insulin delivery through the SteadiSet™ insulin infusion device versus a commercially available insulin infusion setTime frame: up to 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Medizinische Universität Graz
Graz, Austria
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.